Table 1: Socio-demographic, clinical and laboratory and treatment factors of adults with newly diagnosed type 2 diabetes patients at chronic follow-up clinic of University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia, 2020 (n = 400).

Variable	Category	Frequency	Percent (%)
Sex	Male	241	60.25
Sex	Female	159	39.75
Age	< 40	105	26.25
	40-49	75	18.75
	50-59	95	23.75
	60-69	84	21.00
	70-79	34	8.50
	≥ 80	7	1.75
Marital status	Single	27	6.75
	Married	311	77.75
	Divorced	22	5.50
	Widowed	40	10.0
Residence	Urban	231	57.75
Residence	Rural	169	42.25
Occupation	Gov’t employee	73	18.25
	Private work	90	22.50
	Farmer	82	20.50
	Unemployed	12	3.00
	Housewife	95	23.75
	Retired	40	10.0
	Others	8	2.0
Hypertension	Yes	225	56.25
Hypertension	No	175	43.75
Congestive heart failure	Yes	103	25.75
Congestive heart failure	No	297	74.25
Chronic kidney disease	Yes	38	9.5
Chronic kidney disease	No	362	90.5
Stroke	Yes	31	7.75
Stroke	No	369	92.25
Diabetic neuropathy	Yes	68	17
Diabetic neuropathy	No	332	83
Total cholesterol, mg/dl	< 200	284	71
Total cholesterol, mg/dl	≥ 200	116	29
Triglyceride, mg/d	< 150	284	71
Triglyceride, mg/d	≥ 150	116	29
LDL cholesterol, mg/dl	< 100	226	56.50
LDL cholesterol, mg/dl	≥ 100	174	43.50
HDL cholesterol, mg/dl	< 40	154	38.5
HDL cholesterol, mg/dl	≥ 40	246	61.5
Insulin exposure	Yes	129	32.25
Insulin exposure	No	271	67.75
Aspirin exposure	Yes	187	46.75
Aspirin exposure	No	213	53.25